Evidence map›Paper›PMID 21342661›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2011

Molecular modeling and in vivo imaging can identify successful flexible triazine dendrimer-based siRNA delivery systems.

Olivia M Merkel, Mengyao Zheng, Meredith A Mintzer, Giovanni M Pavan, Damiano Librizzi, Marek Maly, Helmut Höffken, Andrea Danani, Eric E Simanek, Thomas Kissel

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Engineering poly- and micelleplexes for nucleic acid delivery - A reflection on their endosomal escape.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Review
  3. Can pulmonary RNA delivery improve our pandemic preparedness?Journal of controlled release : official journal of the Controlled Release Society · 2022
    Article
  4. Two Decades of Triazine Dendrimers.Molecules (Basel, Switzerland) · 2021
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. siRNA delivery to the lung: what's new?Advanced drug delivery reviews · 2014
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Olivia M MerkelDepartment of Pharmaceutics and Biopharmacy, Philipps-Universität, Marburg, Germany. Olivia.merkel@staff.uni-marburg.de
Mengyao Zheng
Meredith A Mintzer
Giovanni M Pavan
Damiano Librizzi
Marek Maly
Helmut Höffken
Andrea Danani
Eric E Simanek
Thomas Kissel
Philipps University of Marburg · DEUniversitätsklinikum Gießen und Marburg · DEUniversity of Applied Sciences and Arts of Southern Switzerland · CHBoston University · USInje University · KRTexas Christian University · US

Funding

Molecular Recognition in Dendrimers Based on MelamineR01GM064560 · NIGMS · TEXAS CHRISTIAN UNIVERSITY · PI SIMANEK, ERIC E · 2002 to 2009
$2.3M
NIGMS NIH HHS R01 GM064560NIGMS NIH HHS R01GM65460
6 · The paper itself

Abstract

This study aimed to identify suitable siRNA delivery systems based on flexible generation 2-4 triazine dendrimers by correlating physico-chemical and biological in vitro and in vivo properties of the complexes with thermodynamic parameters calculated using molecular modeling. The siRNA binding properties of the dendrimers and PEI 25 kDa were simulated, binding and stability were measured in SYBR Gold assays, and hydrodynamic diameters, zeta potentials, and cytotoxicity were quantified. These parameters were compared with cellular uptake of the complexes and their ability to mediate RNAi. Radiolabeled complexes were administered intravenously, and pharmacokinetic profiles and biodistribution of these polyplexes were assessed both invasively and non-invasively. All flexible triazine dendrimers formed thermodynamically more stable complexes than PEI. While PEI and the generation 4 dendrimer interacted more superficially with siRNA, generation 2 and 3 virtually coalesced with siRNA, forming a tightly intertwined structure. These dendriplexes were therefore more efficiently charge-neutralized than PEI complexes, reducing agglomeration. This behavior was confirmed by results of hydrodynamic diameters (72.0 nm-153.5 nm) and zeta potentials (4.9 mV-21.8 mV in 10 mM HEPES) of the dendriplexes in comparison to PEI complexes (312.8 nm-480.0 nm and 13.7 mV-17.4 mV in 10 mM HEPES). All dendrimers, even generation 3 and 4, were less toxic than PEI. All dendriplexes were efficiently endocytosed and showed significant and specific luciferase knockdown in HeLa/Luc cells. Scintillation counting confirmed that the generation 2 triazine complexes showed more than twofold prolonged circulation times as a result of their good thermodynamic stability. Conversely, generation 3 complexes dissociated in vivo, and generation 4 complexes were captured by the reticulo-endothelial system due to their increased surface charge. Molecular modeling proves very valuable for rationalizing experimental parameters based on the dendrimers' structural properties. Non-invasive molecular imaging predicted the in vivo fate of the complexes. Therefore, both techniques effectively promote the rapid development of safe and efficient siRNA formulations that are stable in vivo.

Indexed as

AnimalsDendrimersHumansMiceMice, Inbred BALB CMolecular Dynamics SimulationRNA InterferenceRNA, Small InterferingTransfectionTriazinesDendrimersRNA, Small InterferingTriazines

Identifiers

PMID21342661
PMCPMC3134114
OpenAlexW2086847600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.